The Drug-Induced Respiratory Disease Website

II - Myocardial dysfunction - Heart failure

II.c

Heart failure (biventricular, congestive)

1

Evidence level

low

IV - Heart block (bundle branch-, AV-block)

IV.a

Heart block (bundle branch- or AV-)

1

Evidence level

low

V - Myocarditis

V.a

Myocarditis (can be fulminate/fulminant)

1

Evidence level

low

XI - Pulmonary vasculopathies

XI.a

Pulmonary arterial hypertension

1

Evidence level

low

XII - Pericardial involvement

XII.b

Pericardial effusion (w/wo tamponade)

1

Evidence level

low

XII.n

Pleuropericarditis - Pleuropericardial effusion (ANA unknown or negative)

1

Evidence level

low

XIII - Thrombosis - Embolism

XIII.a

Pulmonary embolism - Venous thrombosis/thrombo-embolism

1

Evidence level

low

XXIV - Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.a

Pneumonitis (ILD)

2

Evidence level

possible

XXIV.b

Pneumonitis (ILD), acute and/or severe (may cause ARDS)

1

Evidence level

low

XXVIII - Large airway involvement

XXVIII.i

Tongue involvement (edema, glossitis, hematoma)

1

Evidence level

low

XXIX - Small airway involvement

XXIX.a

Bronchospasm - Wheezing - Asthma

1

Evidence level

low

XXIX.i

Exacerbation or deterioration of preexisting COPD

1

Evidence level

low

XXXIII - Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)

XXXIII.a

Path: Myocarditis

1

Evidence level

low

XXXIII.f

Path: Myocardial vasculitis

1

Evidence level

low

XXXVI - Autoimmune syndromes - Systemic reactions or conditions

XXXVI.f

Anaphylaxis - Anaphylactoid reaction (either of these can be fatal)

1

Evidence level

low

XXXVI.h

Myasthenia gravis - Myasthenic-like syndrome

1

Evidence level

low

XXXVI.v

Temporal arteritis (Horton’s)

1

Evidence level

low

XXXVI.ad

Polymyalgia rheumatica

1

Evidence level

low